BRIEF published on 04/08/2025 at 07:51, 1 year 2 months ago GenSight Biologics Dépose son Document d’Enregistrement Universel 2024 AMF Thérapie Génique Document D'enregistrement GenSight Biologics Rétine
BRIEF published on 04/08/2025 at 07:51, 1 year 2 months ago GenSight Biologics Files its 2024 Universal Registration Document AMF Gene Therapy Registration Document GenSight Biologics Retina
BRIEF published on 04/08/2025 at 07:48, 1 year 2 months ago GenSight Biologics Files 2024 Universal Registration Document Universal Registration Document GenSight Biologics Gene Therapies Retinal Diseases Financial Report 2024
BRIEF published on 04/08/2025 at 07:48, 1 year 2 months ago GenSight Biologics dépose son document d'enregistrement universel 2024 Document D'Enregistrement Universel GenSight Biologics Thérapies Géniques Maladies De La Rétine Rapport Financier 2024
PRESS RELEASE published on 04/08/2025 at 07:46, 1 year 2 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS GenSight Biologics met à disposition son Document d'Enregistrement Universel 2024 pour consultation en ligne Document D'Enregistrement Universel GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Rétine
PRESS RELEASE published on 04/08/2025 at 07:43, 1 year 2 months ago INSIDE INFORMATION / OTHER NEWS RELEASES GenSight Biologics announces the filing of its 2024 Universal Registration Document with the French market authority, including financial reports and corporate governance details GenSight Biologics Gene Therapies Retinal Neurodegenerative Diseases 2024 Universal Registration Document Central Nervous System Disorders
BRIEF published on 04/07/2025 at 20:19, 1 year 2 months ago GenSight Biologics Financial and Business Update Fundraising Clinical Trials Gene Therapy Financial Update GenSight Biologics
BRIEF published on 04/07/2025 at 20:19, 1 year 2 months ago Mise à jour financière et commerciale de GenSight Biologics Essais Cliniques Thérapie Génique Mise À Jour Financière Collecte De Fonds GenSight Biologics
PRESS RELEASE published on 04/07/2025 at 20:14, 1 year 2 months ago Inside Information / News release on accounts, results GenSight Biologics reports cash position and business update as of March 31, 2025. Discussions with French agency progressing. Fundraising planned for Phase III trial and marketing advancement Business Update Cash Position Fundraising Activities GenSight Biologics RECOVER Phase III Trial
PRESS RELEASE published on 04/07/2025 at 20:14, 1 year 2 months ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa situation de trésorerie au 31 mars 2025, annonce des activités de levées de fonds pour prolonger l'horizon de trésorerie et fait le point sur ses activités Trésorerie Essai Clinique GenSight Biologics Thérapies Géniques Levées De Fonds
Published on 06/24/2026 at 00:00, 23 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 38 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 1 hour 3 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 1 hour 8 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/23/2026 at 23:00, 1 hour 23 minutes ago International Battery Metals Ltd. Announces RSU Grant
Published on 06/23/2026 at 22:20, 2 hours 3 minutes ago Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Published on 06/23/2026 at 20:15, 4 hours 8 minutes ago EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 18:30, 5 hours 53 minutes ago IEVA GROUP: COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ANNUELLE DU 23 JUIN 2026
Published on 06/23/2026 at 17:55, 6 hours 28 minutes ago ABO Energy ABO Energy drives strategic development and future financing solution forward
Published on 06/23/2026 at 19:47, 4 hours 35 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 4 hours 35 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 5 hours 13 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 5 hours 13 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 5 hours 51 minutes ago Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix
